Skip to main content
SpringerLink
Log in

Perceptions and behaviors of patients and pharmacists towards generic drug substitution in Lebanon

  • Research Article
  • Published:
International Journal of Clinical Pharmacy Aims and scope Submit manuscript

Abstract

Background Patients, physicians and pharmacists are key stakeholders in the implementation of generic substitution policies. Objectives To explore Lebanese patients’ perceptions and experience, and pharmacists’ dispensing patterns towards the newly enacted unified health prescription policy promoting generic substitution. Setting Pharmacies in Beirut, the capital of Lebanon. Methods A cross-sectional design employing self-administered questionnaires to survey a total of 128 patients and 25 pharmacists. Chi square test and multiple logistic regression were performed. Main outcome Perceptions and behaviors of patients and pharmacists towards the unified health prescription and generic substitution. Results Fourty-eight percent of the patients knew the definition of generic drugs, among which 59.0% perceived that generic drugs have the same effectiveness as their branded alternatives and 59.0% perceiving that generic drugs could reduce Lebanon’s medical bill as well. Sixty-one percent of the patients were aware of the unified health prescription. Only 13.6% of the pharmacists suggested to patients to replace prescribed brand drug by a generic when their prescriptions were not marked with non-substitution. Conclusions Progress has been made with regards to enhancing generic substitution in the Lebanese healthcare field. However, it remains important to educate patients about generic medicines and plan context-specific schemes that promote prescribing and dispensing of generic drugs among physicians and pharmacists.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. World Health Organization. How to develop and implement a national drug policy, Geneva. 2002. http://www.who.int/management/background_4b.pdf. Accessed Aug 2017.

  2. Andersson K, Bergström G, Petzold MG, Carlsten A. Impact of a generic substitution reform on patients’ and society’s expenditure for pharmaceuticals. Health Policy. 2007;81(2):376–84.

    Article  PubMed  Google Scholar 

  3. Gerdtham U-G, Lundin D. Why did drug spending increase during the 1990s? Pharmacoeconomics. 2004;22(1):29–42.

    Article  PubMed  Google Scholar 

  4. Heikkilä R, Mäntyselkä P, Hartikainen-Herranen K, Ahonen R. Customers’ and physicians’ opinions of and experiences with generic substitution during the first year in Finland. Health Policy. 2007;82(3):366–74.

    Article  PubMed  Google Scholar 

  5. Kobayashi E, Karigome H, Sakurada T, Satoh N, Ueda S. Patients’ attitudes towards generic drug substitution in Japan. Health Policy. 2011;99(1):60–5.

    Article  PubMed  Google Scholar 

  6. Andersson K, Sonesson C, Petzold M, Carlsten A, Lönnroth K. What are the obstacles to generic substitution? An assessment of the behaviour of prescribers, patients and pharmacies during the first year of generic substitution in Sweden. Pharmacoepidemiol Drug Saf. 2005;14(5):341–8.

    Article  PubMed  Google Scholar 

  7. Fabiano V, Mameli C, Cattaneo D, Delle Fave A, Preziosa A, Mele G, et al. Perceptions and patterns of use of generic drugs among Italian family pediatricians: first round results of a web survey. Health Policy. 2012;104(3):247–52.

    Article  PubMed  Google Scholar 

  8. Fischer MA, Avorn J. Economic consequences of underuse of generic drugs: evidence from Medicaid and implications for prescription drug benefit plans. Health Serv Res. 2003;38(4):1051–64.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Fischer MA, Avorn J. Potential savings from increased use of generic drugs in the elderly: what the experience of Medicaid and other insurance programs means for a Medicare drug benefit. Pharmacoepidemiol Drug Saf. 2004;13(4):207–14.

    Article  PubMed  Google Scholar 

  10. Garattini L, Tediosi F. A comparative analysis of generics markets in five European countries. Health Policy. 2000;51(3):149–62.

    Article  CAS  PubMed  Google Scholar 

  11. McManus P, Birkett DJ, Dudley J, Stevens A. Impact of the minimum pricing policy and introduction of brand (generic) substitution into the pharmaceutical benefits scheme in Australia. Pharmacoepidemiol Drug Saf. 2001;10(4):295–300.

    Article  CAS  PubMed  Google Scholar 

  12. Hellerstein JK. The importance of the physician in the generic versus trade-name prescription decision. Rand J Econ. 1998;29(1):108–36.

    Article  CAS  PubMed  Google Scholar 

  13. Karim SA, Pillai G, Ziqubu-Page T, Cassimjee M, Morar M. Potential savings from generic prescribing and generic substitution in South Africa. Health policy Plan. 1996;11(2):198–202.

    Article  CAS  PubMed  Google Scholar 

  14. King DR, Kanavos P. Encouraging the use of generic medicines: implications for transition economies. Croatian Med J. 2002;43(4):462–9.

    Google Scholar 

  15. Lofgren H. Generic drugs: international trends and policy developments in Australia. Aust Health Rev. 2004;27(1):39–48.

    Article  PubMed  Google Scholar 

  16. Kjoenniksen I, Lindbaek M, Granas AG. Patients’ attitudes towards and experiences of generic drug substitution in Norway. Pharm World Sci. 2006;28(5):284–9.

    Article  PubMed  Google Scholar 

  17. OECD. Health at a Glance 2013: OECD indicators. 2013. https://www.oecd.org/els/health-systems/Health-at-a-Glance-2013.pdf. Accessed Aug 2017.

  18. MOPH. Launching of the unified medical prescription (2011). http://www.moph.gov.lb/Media/Pages/Launchoftheunifiedmedicprescription.aspx. Accessed 13 Nov 2015.

  19. Mahdi H. Unified prescription form: NSSF in the service of drug monopolies. Al Akhbar. 2015 Tuesday, 10 Feb 2015.

  20. Olsson E, Kälvemark Sporrong S. Pharmacists’ experiences and attitudes regarding generic drugs and generic substitution: two sides of the coin. Int J Pharm Pract. 2012;20(6):377–83.

    Article  PubMed  Google Scholar 

  21. Yousefi N, Mehralian G, Peiravian F, NourMohammadi S. Consumers’ perception of generic substitution in Iran. Int J Clin Pharm. 2015;37(3):497–503.

    Article  PubMed  Google Scholar 

  22. Figueiras MJ, Marcelino D, Cortes MA. People’s views on the level of agreement of generic medicines for different illnesses. Pharm World Sci. 2008;30(5):590–4.

    Article  PubMed  Google Scholar 

  23. Banahan BF, Kolassa E. A physician survey on generic drugs and substitution of critical dose medications. Arch Intern Med. 1997;157(18):2080–8.

    Article  PubMed  Google Scholar 

  24. Ganther JM, Kreling DH. Consumer perceptions of risk and required cost savings for generic prescription drugs. J Am Pharm Assoc (1996). 2000;40(3):378–83.

    Article  CAS  Google Scholar 

  25. Hassali MA, Shafie AA, Jamshed S, Ibrahim MI, Awaisu A. Consumers’ views on generic medicines: a review of the literature. Int J Pharm Pract. 2009;17(2):79–88.

    PubMed  Google Scholar 

  26. Shrank WH, Cadarette SM, Cox E, Fischer MA, Mehta J, Brookhart AM, et al. Is there a relationship between patient beliefs or communication about generic drugs and medication utilization? Med Care. 2009;47(3):319.

    Article  PubMed  PubMed Central  Google Scholar 

  27. Suh DC. Trends of generic substitution in community pharmacies. Pharm World Sci. 1999;21(6):260–5.

    Article  CAS  PubMed  Google Scholar 

  28. Hamadeh GN, Dickerson LM, Saab BR, Major SC. Common prescriptions in ambulatory care in Lebanon. Ann Pharmacother. 2001;35(5):636–40.

    Article  CAS  PubMed  Google Scholar 

  29. Sharif S, Al-Shaqra M, Hajjar H, Shamout A, Wess L. Patterns of drug prescribing in a hospital in Dubai, United Arab Emirates. Libyan J Med. 2008;3(1):10–2.

    Article  PubMed  PubMed Central  Google Scholar 

  30. Irshaid Y, Al Homrany M, Hamdi A, Adjepon Yamoah K, Mahfouz A. Compliance with good practice in prescription writing at outpatient clinics in Saudi Arabia. 2005. Retrieved from http://apps.who.int/iris/handle/10665/117022.

  31. Chong CP, March G, Clark A, Gilbert A, Hassali MA, Bahari MB. A nationwide study on generic medicines substitution practices of Australian community pharmacists and patient acceptance. Health Policy. 2011;99(2):139–48.

    Article  PubMed  Google Scholar 

  32. Grover P, Stewart J, Hogg M, Short L, Seo HG, Rew A. Evaluating pharmacists’ views, knowledge, and perception regarding generic medicines in New Zealand. Res Soc Adm Pharm. 2011;7(3):294–305.

    Article  Google Scholar 

  33. Colgan S, Faasse K, Martin LR, Stephens MH, Grey A, Petrie KJ. Perceptions of generic medication in the general population, doctors and pharmacists: a systematic review. BMJ Open. 2015;5(12):e008915.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

The authors wish to thank all the patients and pharmacists who participated in the survey. We also thank Ms. Angie Farah for her contribution.

Funding

This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

Conflicts of interest

The authors declare that they have no conflict of interest.

Ethics approval

The American University of Beirut’s Institutional Review Board approved the protocol from March 8, 2016 to March 7, 2017 inclusive (FHS.SS.17).

Informed consent

Informed consent was obtained from all individual participants included in the study.

Author information

Authors and Affiliations

  1. Department of Health Management and Policy, Faculty of Health Sciences, American University of Beirut, Riad El Solh, Beirut, 1107 2020, Lebanon

    Shadi Saleh, Clara Abou Samra, Stewart Jleilaty, Joanne Constantin, Nour El Arnaout & Dania Al-Bittar

  2. School of Pharmacy, Lebanese American University, Beirut, Lebanon

    Hani Dimassi

Authors
  1. Shadi Saleh
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Clara Abou Samra
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Stewart Jleilaty
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Joanne Constantin
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Nour El Arnaout
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Hani Dimassi
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Dania Al-Bittar
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Shadi Saleh.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Saleh, S., Abou Samra, C., Jleilaty, S. et al. Perceptions and behaviors of patients and pharmacists towards generic drug substitution in Lebanon. Int J Clin Pharm 39, 1101–1109 (2017). https://doi.org/10.1007/s11096-017-0509-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11096-017-0509-4

Keywords

Search

Navigation